With a rich background in venture capital, the fund manager has successfully executed over 50 deals across technology and healthcare sectors, particularly in Europe and North America. Emphasizing a data-driven approach, the manager has cultivated a robust portfolio, marked by several notable exits, including a lucrative sale in the biotech space. Active in early to growth-stage investments, the focus remains on identifying thematic trends that drive innovation. This strategic style fosters partnerships with visionary founders, enhancing long-term value creation.